Corcept Therapeutics Inc
CORT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001088856
In the last 90 days, Corcept Therapeutics Inc insiders filed 0 open-market purchases and 20 sales; 424 institutions reported holding it in 13F filings for Q2 2026, worth $7.15B in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Corcept Therapeutics Inc changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 208 | 2 | 228 | +22 |
| Shares | 80.6M | 10.2K | 81.4M | +815.9K (+1.0%) |
| Value | $1.59B | $202.0K | $1.84B | +$242.2M (+15.2%) |
2 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (41)
Institutions that held Corcept Therapeutics Inc at the end of Q1 2022 but not at the end of Q4 2021.
Sold out (19)
Institutions that held Corcept Therapeutics Inc at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Aviva PLC | 127,855 | $2.53M |
| Balyasny Asset Management LLC | 111,397 | $2.21M |
| Caas Capital Management LP | 95,608 | $1.89M |
| Capital Impact Advisors, LLC | 72,794 | $1.44M |
| Summit Global Investments | 59,682 | $1.18M |
| Caption Management, LLC | 22,800 | $451.0K |
| Spearhead Capital Advisors, LLC | 16,876 | $334.0K |
| Bank of Nova Scotia | 9,728 | $269.0K |
| Quantbot Technologies LP | 12,126 | $240.0K |
| Zebra Capital Management LLC | 11,388 | $225.0K |
| Quantamental Technologies LLC | 11,026 | $218.0K |
| Rafferty Asset Management, LLC | 10,913 | $216.0K |
| Aigen Investment Management, LP | 10,128 | $201.0K |
| Vestcor Inc | 6,010 | $119.0K |
| Sagefield Capital LP | 4,150 | $82.0K |
| SG3 Management, LLC | 1,500 | $30.0K |
| First Quadrant L P | 1,200 | $24.0K |
| Benjamin Edwards Inc | 463 | $9.00K |
| Bessemer Group Inc | 195 | $4.00K |
Not filed for Q1 2022 yet (2)
Institutions that held Corcept Therapeutics Inc at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| 6 Meridian | 10,149 | $201.0K |
| Bell Investment Advisors, Inc | 48 | $1.00K |